Molbio reappoints cost auditor for FY26-27

Molbio Diagnostics reappointed K. S. Kamalakara & Co. as its cost auditor for FY 2026–27. The decision was taken during a recent board meeting. This is a routine compliance requirement under the Companies Act. No financial impact is expected from this reappointment.

📊 STOCKS: MOLBIOLAB | 🏢 SECTOR: Pharma | #LOWIMPACT #CostAudit